PCRX Investors Invited to Head Class Action Lawsuit Against Pacira BioSciences Over Alleged Securities Fraud
Investors in Pacira BioSciences, Inc., a New Jersey-based pharmaceutical company, have been granted the opportunity to lead a securities class action lawsuit over allegations of fraudulent activity. The lawsuit surrounds claims that Pacira misrepresented its financial status and the efficacy of certain products, thereby inflating its stocks artificially. The legal challenge roots from assertions that Pacira failed to disclose operational and business setbacks, particularly concerning the effectiveness and market acceptance of EXPAREL, a non-opioid pain management drug that is one of the company’s top products. Allegedly, the company made misleading statements or failed to provide … Read more